Infection and Immunity · 1996 · 63 citations · 30 references
Life SciencesImmunologyInfectious DiseasesAdaptive ImmunityCellular ImmunologyVaccine ImmunologyAdaptive Immune ResponsesAntigen RecognitionCell-mediated ImmunityParasite AntigensT Cell ActivationVaccine Antigen DiscoveryAntigen-specific T Cell ResponsesMalaria ImmunologyMalaria VaccinesPeptide EpitopesPlasmodium FalciparumT Cell Epitope RecognitionT-cell EpitopesT-cell Immune Responses
AMA-1 of Plasmodium falciparum is a promising candidate antigen in malaria vaccine development. In this study, we have mapped the immunodominant T-cell determinants in this antigen by using synthetic peptides. From the amphipathic scores, 17 putative T-cell determinants were identified. Nine of the 17 peptides complementary to the putative T-cell determinants induced proliferation of peripheral blood mononuclear cells (PBMC) from Kenyan residents who had lifelong exposure to malaria; none of these peptides induced proliferation of PBMC from donors who were not previously exposed to malaria. This indicates that AMA-1 peptides were stimulating T cells that were previously primed by prior exposure to P. falciparum. Many positive responders showed reactivity to more than one peptide, and some of the potent proliferative T epitopes were found to be localized in the highly conserved regions of AMA-1, suggesting that it may be possible to induce T-cell memory that can recognize different variant forms of the parasite. This information on the natural immune responses against the AMA-1 vaccine antigen in clinically immune adults will be helpful in the development of an AMA-1 antigen-based malaria vaccine and may also guide testing of AMA-1-based vaccine formulations.
30
Why do some African children develop severe malaria?
Brian Greenwood, Kevin Marsh, Robert W. Snow · Parasitology Today · 1991 · 332 citations